Sudarshan Pharma Industries Ltd

Sudarshan Pharma Industries Ltd has a debt-to-equity ratio of 1.3, indicating a moderate reliance on debt financing, and a current ratio of 1.29, suggesting limited short-term liquidity cushion. The company's liquidity position is assessed as medium, with negative net cash after subtracting total debt, signaling potential refinancing or cash flow management challenges. The company's profitability is modest, with a return on equity (ROE) of 12.13% and a return on assets (ROA) of 3.96%. These figures are below the typical thresholds for pharmaceutical firms, which often aim for ROE above 15% and ROA above 5%, indicating that Sudarshan Pharma is underperforming relative to industry expectations. Geographically, Sudarshan Pharma's revenue is concentrated in India, with operations in Maharashtra, Gujarat, and Uttarakhand. The company also exports specialty chemicals and APIs, but the extent of international revenue is not disclosed. This concentration may expose the company to domestic regulatory and economic risks. The company's growth trajectory is not clearly defined in the available data. While it engages in contract manufacturing and exports, there is no indication of revenue growth or expansion plans. The capital expenditure for the period is negative at -INR 5.86 million, suggesting a reduction in investment in physical assets, which could signal a conservative or cost-cutting strategy. Risk factors include medium liquidity risk due to limited cash reserves and a high debt load, as well as potential dilution risk, though it is currently assessed as low. The company's financial leverage and limited free cash flow may constrain its ability to invest in growth or withstand economic downturns. Recent events or filings are not detailed in the provided data, but the company's financial snapshot and risk assessment suggest a need for close monitoring of liquidity and debt management. The absence of recent capital expenditures and the negative net cash position may indicate a focus on debt reduction or operational efficiency.